Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $43 | $36 | $33 | $125 |
| Short-Term Investments | $408 | $417 | $440 | $407 |
| Receivables | $17 | $20 | $18 | $14 |
| Inventory | $7 | $7 | $4 | $3 |
| Other Curr. Assets | $15 | $15 | $14 | $13 |
| Total Curr. Assets | $490 | $494 | $509 | $562 |
| Property Plant & Equip (Net) | $5 | $5 | $5 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $19 | $20 | $20 | $16 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $24 | $25 | $26 | $20 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $514 | $519 | $534 | $583 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $3 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $5 | $0 |
| Deferred Revenue | $2 | $2 | $2 | $2 |
| Other Curr. Liab. | $48 | $44 | $39 | $69 |
| Total Curr. Liab. | $56 | $51 | $48 | $73 |
| LT Debt | $3 | $3 | $3 | $3 |
| Deferred Rev, NC | $3 | $3 | $3 | $3 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $6 | $7 | $7 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $3 | $3 |
| Total Liabilities | $63 | $58 | $55 | $80 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$640 | -$620 | -$590 | -$554 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $1,091 | $1,081 | $1,070 | $1,057 |
| Total Equity | $451 | $461 | $480 | $503 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $514 | $519 | $534 | $583 |
| Net Debt | -$40 | -$33 | -$30 | -$122 |